https://www.neurologyadvisor.com/topics/neuromuscular-disorders/rituximab-reduces-risk-disease-manifestation-new-onset-myasthenia-gravis/
0
0
Rituximab Reduces Risk for Disease Manifestation in New-Onset Myasthenia Gravis - Neurology Advisor
10/18/22 at 3:06pm
Organization
Neurologyadvisor.com
Author
Emily Estrada
In a randomized clinical trial, researchers investigated the efficacy and safety of rituximab compared with placebo for patients with myasthenia gravis.
Create an account or login to join the discussion